Valuation : Clover Corporation Limited

Market Cap 147M 106M 91M 85.39M 78.13M 146M 10B 1.01B 393M 5.11B 397M 388M 16.45B P/E 2026 *
15.1x
P/E 2027 * 11x
Enterprise Value 145M 104M 89.57M 84.06M 76.9M 144M 9.84B 994M 387M 5.03B 391M 382M 16.2B EV / Sales 2026 *
1.54x
EV / Sales 2027 * 1.2x
Free-Float
76.93%
Yield 2026 *
-
Yield 2027 * -
1 day+7.34%
1 week+4.97%
Current month+3.83%
1 month+1.06%
3 months+0.53%
6 months+23.38%
Current year+20.25%
1 week 0.87
Extreme 0.87
0.96
1 month 0.87
Extreme 0.87
1
Current year 0.7
Extreme 0.7
1.16
1 year 0.52
Extreme 0.525
1.16
3 years 0.34
Extreme 0.337
1.16
5 years 0.34
Extreme 0.337
1.8
10 years 0.34
Extreme 0.337
3.31
Manager TitleAgeSince
Chief Executive Officer - 11/11/2014
Director of Finance/CFO - 06/05/2021
Chief Operating Officer - 03/02/2011
Director TitleAgeSince
Director/Board Member - 11/11/2014
Chairman - 21/09/2017
Director/Board Member - 01/02/2017
Date Insider Type Main position Quantity % Market Cap. Importance
18/11/25 Sell

Chief Executive Officer

255,199 0.1528%
18/11/25 Buy

Chief Executive Officer

529,638 0.3171%
6/11/25 Buy

Chief Financial Officer

2,447 0.0015%
Change 5-day change 1-year change 3-year change Capi.($)
+7.34%+4.97%+68.14%-6.86% 106M
+0.52%-0.37%+11.04%+65.19% 12.2B
-0.81%-6.54%-22.12%+254.11% 9.17B
+1.23%+0.41%-16.57%-49.07% 2.43B
+2.90%-1.24%-17.69%-6.29% 1.47B
+0.13%-0.18%+22.89%+79.37% 1.37B
-0.78%-2.25%+20.42%-17.18% 1.28B
-0.38%-3.32%-75.78%-74.70% 1.21B
-2.89%+4.44%-36.83% - 1.16B
-1.17%+3.48%-60.36%-66.10% 1.02B
Average +0.61%+1.42%-10.69%+19.83% 3.14B
Weighted average by Cap. +0.04%+0.19%-8.46%+96.70%

Financials

2026 *2027 *
Net sales 94M 67.64M 58.2M 54.61M 49.97M 93.26M 6.39B 646M 252M 3.27B 254M 248M 10.52B 116M 83.54M 71.88M 67.45M 61.72M 115M 7.9B 798M 311M 4.04B 314M 307M 13B
Net income 9.8M 7.05M 6.07M 5.69M 5.21M 9.72M 667M 67.36M 26.23M 341M 26.48M 25.9M 1.1B 13.5M 9.71M 8.36M 7.84M 7.18M 13.39M 918M 92.79M 36.13M 469M 36.48M 35.68M 1.51B
Net Debt -2.3M -1.66M -1.42M -1.34M -1.22M -2.28M -156M -15.81M -6.16M -79.95M -6.21M -6.08M -257M -7.2M -5.18M -4.46M -4.18M -3.83M -7.14M -490M -49.49M -19.27M -250M -19.46M -19.03M -806M
Logo Clover Corporation Limited
Clover Corporation Limited focused on technology, new product development, and commercialization. The principal activities of the Company are the refining and sale of natural oils, the production of encapsulated powders and the research and product development of functional food and infant nutrition ingredients. Its microencapsulation technology enables nutritional oils, such as tuna, fish, algal and fungal oils, to be added to infant formulas, foods, and beverages. Its technologies protect those sensitive oils from oxidation, allowing them to be incorporated into a range of applications. The Company, through its subsidiary, Nu-Mega Ingredients Pty Limited (Nu-Mega), supplies refined Omega-3 oils and a range of other encapsulated ingredients for use in infant formula, nutraceuticals, pharmaceuticals, and sports nutrition markets. Nu-Mega’s Driphorm range of microencapsulated powders enables the addition of Hi-DHA tuna and/or algal oils to a broad spectrum of products.
Employees
68
Date Price Change Volume
04/09/26 $0.9500 +7.34% 117,767
03/09/26 $0.8850 +1.72% 15,479
01/09/26 $0.8700 -4.92% 26,873
31/08/26 $0.9150 -6.15% 11,960
28/08/26 $0.9750 +7.73% 18,009
Trader
-
Investor
Global
-
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.8850AUD
Average target price
1.280AUD
Spread / Average Target
+44.63%

Annual profits - Rate of surprise